Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Novostent
AddedFeb 15, 2024
UpdatedJun 18, 2026
Novostent

Novostent

Pre-Seed

NovoStent Corp: Innovating stent technologies for vascular treatments across the US healthcare sector.

HQ
Mountain View, CA, US
Founded
2003
Overview
Compare
Fundraising
Employees

Novostent is a medical device company focused on innovating stent technologies for vascular treatments. They offer surgical and medical instruments, including vascular stents and delivery systems, aimed at addressing vascular issues and diseases. Their primary market focus is the healthcare sector throughout the United States.

Novostent has made significant strides in the medical device industry, contributing to advancements in vascular treatment. Their products have impacted patient care by providing effective solutions for vascular health. The company continues to be a key player in the US healthcare market.

Novostent - Similar Companies

Vascular Dynamics logo

Vascular Dynamics

Svelte Medical Systems logo

Svelte Medical Systems

VenoStent logo

VenoStent

venostent.com

Medlogics Device logo

Medlogics Device

Nanovasc logo

Nanovasc

nanovasc.com

Traverse Vascular logo

Traverse Vascular

Ostial logo

Ostial

ostialcorp.com

Nectero Medical logo

Nectero Medical

necteromed.com

Cross Vascular logo

Cross Vascular

eLum Technologies logo

eLum Technologies

Vaso logo

Vaso

Artio Medical logo

Artio Medical

Venarum Medical logo

Venarum Medical

East End Medical logo

East End Medical

Novogiene logo

Novogiene

Novostent - Quick Facts

Who are Novostent's competitors?

Companies similar to Novostent include Vascular Dynamics, Svelte Medical Systems, VenoStent and Medlogics Device.

When was Novostent founded?

Novostent was founded in 2003.

Where is Novostent's headquarters located?

Novostent's headquarters is located in Mountain View, CA, US.

When was Novostent's last funding round?

Novostent's most recent funding round was for $1.1M (USD) in June 2009.

How much has Novostent raised to-date?

As of Jun 30, 2009, Novostent has raised a total of $14.4M (USD).

How many employees does Novostent have?

Novostent has 6 employees as of Feb 5, 2024.

Novostent - Classification

Industry
  • Hardware
Ownership
  • Private
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
  • Stents
Tags
  • Healthcare
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 11 more industry codes
NAICS
  • 423000Merchant Wholesalers, Durable Goods
  • 423400Professional and Commercial Equipment and Supplies Merchant Wholesalers
  • 423450Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
  • 330000Manufacturing
  • 420000Wholesale Trade
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified